In vitro susceptibility of Malassezia furfur against azole compounds

被引:19
|
作者
Schmidt, A
RuhlHorster, B
机构
[1] Institut für Chemotherapie, Bayer AG, Wuppertal, FR
[2] PH-R-A11, D-42096 Wuppertal
关键词
Malassezia furfur; antifungal agents; azoles; bifonazole; climbazole; clotrimazole; ketoconazole; susceptibility;
D O I
10.1111/j.1439-0507.1996.tb00145.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The minimum inhibitory concentrations (MICs) for 30 isolates of Malassezia furfur of four azole compounds - bifonazole, climbazole, clotrimazole and ketoconazole were determined as these substances are used in the topical therapy of M. furfur-associated skin conditions. M. furfur is a lipophilic fungus with complex growth requirements; the MICs were measured in a microdilution test system in modified Leeming-Notman medium by a colorimetric read-out with alamarBlue(TM). The MICs of bifonazole ranged between <9.06 and 1 mu g ml(-1) with an empirical median of 0.06 mu g ml(-1), for climbazole the MICs were < 0.06 to 0.5 mu g ml(-1) (median < 0.06 mu g ml(-1)), for clotrimazole < 0.06 to 8 mu g ml(-1) (median 1 mu g ml(-1)), and for ketoconazole <0.06 to 0.12 mu g ml(-1) (median < 0.06 mu g ml(-1)). Climbazole and ketoconazole showed similar in vitro activity against M. furfur, with bifonazole having slightly lower, and clotrimazole the lowest in vitro activity. These findings may be explained by the extremely low water solubility of the last two compounds; the results have yet to be correlated with the in vivo efficacy of these substances.
引用
收藏
页码:309 / 312
页数:4
相关论文
共 50 条
  • [1] In vitro susceptibility of Malassezia furfur
    Schmidt, A
    RuhlHorster, B
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1996, 46 (04): : 442 - 444
  • [2] In vitro susceptibility testing of Malassezia furfur against rilopirox
    Nenoff, P
    Haustein, UF
    SKIN PHARMACOLOGY, 1997, 10 (5-6): : 275 - 280
  • [3] Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values
    Cafarchia, Claudia
    Iatta, Roberta
    Immediato, Davide
    Puttilli, Maria Rita
    Otranto, Domenico
    MEDICAL MYCOLOGY, 2015, 53 (07) : 743 - 748
  • [4] Azole Resistance Mechanisms in Pathogenic Malassezia furfur
    Leong, Cheryl
    Kit, Joel Chan Wai
    Lee, Shi Mun
    Lam, Yuen In
    Goh, Joleen P. Z.
    Ianiri, Giuseppe
    Dawson, Thomas L., Jr.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (05)
  • [5] In vitro antifungal susceptibility of Malassezia furfur from bloodstream infections
    Latta, Roberta
    Figueredo, Luciana A.
    Montagna, Maria Teresa
    Otranto, Domenico
    Cafarchia, Claudia
    JOURNAL OF MEDICAL MICROBIOLOGY, 2014, 63 : 1467 - 1473
  • [6] In vitro susceptibility of Malassezia furfur to the essential oil of Melaleuca alternifolia
    Hammer, KA
    Carson, CF
    Riley, TV
    JOURNAL OF MEDICAL AND VETERINARY MYCOLOGY, 1997, 35 (05): : 375 - 377
  • [7] Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method
    Rojas, Florencia D.
    Sosa, Maria de los A.
    Fernandez, Mariana S.
    Cattana, Maria E.
    Cordoba, Susana B.
    Giusiano, Gustavo E.
    MEDICAL MYCOLOGY, 2014, 52 (06) : 641 - 646
  • [8] In vitro activity of phytosphingosines against Malassezia furfur and Candida albicans
    Nenoff, P
    Haustein, UF
    ACTA DERMATO-VENEREOLOGICA, 2002, 82 (03) : 170 - 173
  • [9] Susceptibility of Malassezia furfur subgroups to terbinafine
    Leeming, JP
    Sansom, JE
    Burton, JL
    BRITISH JOURNAL OF DERMATOLOGY, 1997, 137 (05) : 764 - 767
  • [10] IN-VITRO ACTIVITY OF LITHIUM SUCCINATE AGAINST MALASSEZIA-FURFUR
    NENOFF, P
    HAUSTEIN, UF
    MUNZBERGER, C
    DERMATOLOGY, 1995, 190 (01) : 48 - 50